In a mouse squamous cell carcinoma model (SCC-VII), HF10 significantly reduced tumor growth despite increased PD-L1 expression on tumor and immune cells, and increased CD8+ PD-1− TILs in both injected and non-injected tumors [52]. Here, CD8A is linked to neoplasm.